1. Ultrasound Elastography Combined With BI-RADS–US Classification System: Is It Helpful for the Diagnostic Performance of Conventional Ultrasonography?
- Author
-
Hui Zhi, Xin-Bao Zhao, Bao-Ming Luo, Jiyi Yao, Lu-Jing Li, Qiong-Chao Jiang, Bing Ou, Wen-Jing Zhong, and Shao-Yun Hao
- Subjects
Adult ,Cancer Research ,medicine.medical_specialty ,Adolescent ,Breast imaging ,Breast Neoplasms ,BI-RADS ,Malignancy ,Sensitivity and Specificity ,030218 nuclear medicine & medical imaging ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,medicine ,Humans ,Aged ,Retrospective Studies ,Aged, 80 and over ,Receiver operating characteristic ,medicine.diagnostic_test ,business.industry ,Ultrasound ,Retrospective cohort study ,Middle Aged ,medicine.disease ,ROC Curve ,Oncology ,Area Under Curve ,030220 oncology & carcinogenesis ,Elasticity Imaging Techniques ,Female ,Ultrasonography, Mammary ,Radiology ,Elastography ,business - Abstract
To evaluate the additive diagnostic performance of ultrasound elastography (UE) to ultrasound (US) with the 2003 or 2013 Breast Imaging Reporting and Data System (BI-RADS)-US classification systems for the differentiation of benign and malignant breast lesions.From June 2010 to December 2012, 738 women with 770 breast lesions were recruited into this retrospective study. Breast lesions were evaluated separately by US, UE, and both. US assessment was based on the 2003 or 2013 BI-RADS-US, and UE assessment was based on a previously reported 5-point scale. Diagnostic performance of US, UE, and both was compared.Before category 4 lesions were subdivided, the area under the receiver operating characteristic curve (AUC) for US, UE, and both were, respectively, 0.735, 0.877, 0.878 (P .01). When subcategories of 4 lesions were considered, the AUC for US, UE, and both were, respectively, 0.865, 0.877, and 0.883 (P.05). Adding UE to analysis of 4A lesions can decrease the percentages of malignancy to 2.56%.When the 2003 BI-RADS was considered, UE could give US some help in differentiating breast lesions. However, when the 2013 BI-RADS was considered, UE gave little help to US, although it reduced unnecessary biopsies of benign category 4A lesions.
- Published
- 2016
- Full Text
- View/download PDF